Literature DB >> 19136018

Unilateral left prosopometamorphopsia: a neuropsychological case study.

Luigi Trojano1, Massimiliano Conson, Sara Salzano, Valentino Manzo, Dario Grossi.   

Abstract

We describe a patient who suddenly developed prosopometamorphopsia after a childbirth; she claimed that the left half of well-known and unfamiliar faces looked distorted. Brain MR was normal, whereas SPECT showed hypoperfusion of the left infero-lateral occipital cortex. No visual recognition defects for objects or faces were present. In three matching tasks with half-faces (Experiment 1), chimeric faces (Experiment 2), or chimeric objects (Experiment 3), the patient was impaired only when she matched pairs of chimeric faces differing in their left half; the same results were obtained after 1 year. This is the first behavioural demonstration of selective chronic metamorphopsia for the left side of faces, and provides new insights for models of face processing.

Entities:  

Mesh:

Year:  2008        PMID: 19136018     DOI: 10.1016/j.neuropsychologia.2008.12.015

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  3 in total

1.  Lack of awareness despite complex visual processing: Evidence from event-related potentials in a case of selective metamorphopsia.

Authors:  Teresa M Schubert; David Rothlein; Trevor Brothers; Emily L Coderre; Kerry Ledoux; Barry Gordon; Michael McCloskey
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-22       Impact factor: 11.205

2.  Prosopometamorphopsia and alexia following left splenial corpus callosum infarction: Case report and literature review.

Authors:  Connor W McCarty; Gabriel M Gordon; Aimee Walker; Philip Delio; Robert A Kolarczyk; Dante J Pieramici
Journal:  eNeurologicalSci       Date:  2016-08-20

3.  A neurological disorder presumably underlies painter Francis Bacon distorted world depiction.

Authors:  Avinoam B Safran; Nicolae Sanda; José-Alain Sahel
Journal:  Front Hum Neurosci       Date:  2014-08-29       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.